Filing Details
- Accession Number:
- 0001209191-15-031615
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-04-02 17:11:25
- Reporting Period:
- 2015-03-25
- Filing Date:
- 2015-04-02
- Accepted Time:
- 2015-04-02 17:11:25
- Original Submission Date:
- 2015-04-01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1412067 | Oncothyreon Inc. | ONTY | Services-Commercial Physical & Biological Research (8731) | 260868560 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238403 | K Daniel Spiegelman | C/O Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA 98121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-25 | 10,000 | $1.63 | 30,644 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-03-26 | 10,000 | $1.59 | 40,644 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents the aggregate of sales effected on the same day at different prices.
- As the result of a broker administrative error, the Form 4 previously filed with the U.S. Securities and Exchange Commission (the "SEC") incorrectly reported one purchase price for the aggregate of shares purchased. The purchase price is corrected on this amended Form 4. The amended purchase price represents the weighted average purchase price per share. The shares were purchased at prices ranging from $1.62 to $1.63 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
- As the result of a broker administrative error, the Form 4 previously filed with the SEC incorrectly reported one purchase price for the aggregate of shares purchased. The purchase price is corrected on this amended Form 4. The amended purchase price represents the weighted average purchase price per share. The shares were purchased at prices ranging from $1.58 to $1.59 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.